ArticleJournal of oncology2022

Identification of a Metabolic Reprogramming-Associated Risk Model Related to Prognosis, Immune Microenvironment, and Immunotherapy of Stomach Adenocarcinoma.

Yan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.